Young David
SEC insider (Form 3/4/5 filer). CIK 0001378166. Pres. Research & Development at Processa Pharmaceuticals, Inc. (PCSA). 16 reported Form 4/5 transactions since Sep 2024; latest on Jun 30, 2026. Located in VERO BEACH, FL.
Companies Young David has filed insider reports for
- Processa Pharmaceuticals, Inc. (PCSA): Director, Officer, Pres. Research & Development
Young David
CIK: 0001378166
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Processa Pharmaceuticals, Inc.
Discretionary Trading P&L
Holdings
Transaction History (16 total)
- Jun 30, 2026PCSA
Processa Pharmaceuticals, Inc.
PurchaseDirect2.5K shares at avg. $1.93$5K - Jun 15, 2026PCSA
Processa Pharmaceuticals, Inc.
PurchaseDirect2.1K shares at avg. $2.22$5K - May 29, 2026PCSA
Processa Pharmaceuticals, Inc.
PurchaseDirect1.8K shares at avg. $2.57$5K - May 15, 2026PCSA
Processa Pharmaceuticals, Inc.
PurchaseDirect1.5K shares at avg. $2.97$5K - Apr 30, 2026PCSA
Processa Pharmaceuticals, Inc.
PurchaseDirect1.7K shares at avg. $2.69$5K - Apr 15, 2026PCSA
Processa Pharmaceuticals, Inc.
PurchaseDirect1.5K shares at avg. $2.97$5K - Mar 31, 2026PCSA
Processa Pharmaceuticals, Inc.
PurchaseDirect1.8K shares at avg. $2.54$5K - Jan 1, 2026PCSA
Processa Pharmaceuticals, Inc.
ExerciseDirect49 shares- - Oct 1, 2025PCSA
Processa Pharmaceuticals, Inc.
AwardDirectRestricted Stock Units
111K shares- - Oct 1, 2025PCSA
Processa Pharmaceuticals, Inc.
AwardDirectStock Options (Right to Buy)
333K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 30, 2026 | PCSA Processa Pharmaceuticals, Inc. | Purchase | 2,531 | $1.93 | $4,885 | Direct |
| Jun 15, 2026 | PCSA Processa Pharmaceuticals, Inc. | Purchase | 2,067 | $2.22 | $4,589 | Direct |
| May 29, 2026 | PCSA Processa Pharmaceuticals, Inc. | Purchase | 1,786 | $2.57 | $4,590 | Direct |
| May 15, 2026 | PCSA Processa Pharmaceuticals, Inc. | Purchase | 1,545 | $2.97 | $4,589 | Direct |
| Apr 30, 2026 | PCSA Processa Pharmaceuticals, Inc. | Purchase | 1,706 | $2.69 | $4,589 | Direct |
| Apr 15, 2026 | PCSA Processa Pharmaceuticals, Inc. | Purchase | 1,545 | $2.97 | $4,589 | Direct |
| Mar 31, 2026 | PCSA Processa Pharmaceuticals, Inc. | Purchase | 1,810 | $2.54 | $4,588 | Direct |
| Jan 1, 2026 | PCSA Processa Pharmaceuticals, Inc. | Exercise | 49 | - | $0 | Direct |
| Oct 1, 2025 | PCSA Processa Pharmaceuticals, Inc. | Award Restricted Stock Units | 111,000 | - | - | Direct |
| Oct 1, 2025 | PCSA Processa Pharmaceuticals, Inc. | Award Stock Options (Right to Buy) | 333,000 | - | - | Direct |
1-10 of 16 transactions